CD8A and neoplasm: Importantly, we found a significant increase in the number of CD8+ T cells and the ratio of the number of CD8+ T cells per gram of tumor to the number of CD11b+ myeloid cells per gram of tumor with APR-246 combination therapy (Figure 2C).